Phase III Trials Products (Biosimilars)
FY, 2021
Registration Phase Products (Pharmaceuticals)
FY, 2021
Phase I/II Trials Products
FY, 2022
Metrics | FY, 2020 | FY, 2021 | FY, 2022 |
---|---|---|---|
Phase III Trials Products (Biosimilars) | 1 | 2 | |
Registration Phase Products (Pharmaceuticals) | 5 | 2 | |
Phase I/II Trials Products | 118 | 107 | 100 |
Phase III Trials Products | 44 | 54 | 44 |
Registration Phase Products | 5 | 8 | 8 |
Phase I/II Trials Products (Oncology) | 51 | 49 | |
Phase III Trials Products (Oncology) | 22 | 27 | |
Phase I/II Trials Products (Pharmaceuticals) | 67 | 58 | |
Phase III Trials Products (Pharmaceuticals) | 21 | 25 | |
Registration Phase Products (Oncology) | 6 | ||
Patients | 10M |
Community
Employees
Environment
Governance
Source:CSRHub
Ads
Analytics
CDN
Cdn
Cdns
Cms
Copyright
Css
Feeds
Framework
Hosting
Javascript